As the between-visit needs of people living with obesity, including GLP-1 users, outpace the dwindling bandwidth of physicians, virtual care will be increasingly needed to fill the gaps in care, particularly amid concurrent obesity and loneliness epidemics.
Prepared under contract by Health Care Cost Institute, December 2021
(PubMed) Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E
While GLP-1 initiation reduces spending on other diabetes medications by $189 annually, this offset is insufficient to counterbalance increased outpatient costs
Provides elasticity and smoothness for a fresh, revitalised appearance
These BMI thresholds are based on the populations studied during major Semaglutide clinical trials